Legal Calls sells exclusive atrazine leads and signed retainers for law firms evaluating non-Hodgkin lymphoma claims tied to atrazine herbicide exposure. Claimants come from our own Meta, TikTok and Google ads, not affiliates. Our in-house intake team screens each claimant, and we deliver by CRM, API, email or warm transfer.
| Case type | Pesticide exposure (herbicide) product liability |
| Litigation | No MDL; first known NHL suit filed Oct. 2026 (C.D. Cal.), as of November 2026 |
| Alleged injuries | Non-Hodgkin lymphoma; some firms also review aggressive prostate cancer |
| Lead sources | Meta, TikTok & Google ads — no affiliates |
| What you get | Exclusive leads or signed retainers |
| Delivery | CRM, API, email or warm transfer |
| Intake | In-house team, under 1-minute speed-to-lead |
| Proof | TrustedForm certificate, call recordings, ad account access |
| Volume | On request |
| Last reviewed | November 2026 |
As of November 2026, there is no MDL and no consolidated proceeding for atrazine personal-injury claims. The first publicly reported case, Panayiotou v. Syngenta AG, No. 2:26-cv-11652 (C.D. Cal.), was filed on October 6, 2026 by a Los Angeles County applicator who alleges non-Hodgkin lymphoma after about three decades of mixing and spraying atrazine. Syngenta denies the claims, and no court has ruled on the merits.
Interest grew after the International Agency for Research on Cancer (IARC) classified atrazine as Group 2A, “probably carcinogenic to humans,” in November 2025. On October 9, 2026, California’s OEHHA issued a notice of intent to list atrazine as a carcinogen under Proposition 65. Syngenta, maker of AAtrex and other atrazine products, is the primary defendant; investigating firms also name other makers.
In June 2026 the U.S. Supreme Court held 7-2 in Monsanto Co. v. Durnell that FIFRA preempts state failure-to-warn claims seeking warnings beyond the EPA-approved label. The ruling applies to registered pesticides, including atrazine. The Panayiotou complaint pleads design defect, negligence and a failure-to-warn claim based on communications outside the label.
The only prior atrazine resolution was a $105 million settlement in 2012 with community water systems. That was a cost-recovery case, not a personal-injury case.
Sources: Atrazine Lawsuit Update October 2026 – Wisner Baum · Lawsuit Targets Syngenta Over Atrazine – DTN (Oct. 14, 2026) · Notice of Intent to List Chemicals by the Labor Code Mechanism: Atrazine – OEHHA · Supreme Court Rules FIFRA Preempts State Tort Law Claims Against Monsanto Roundup – Polsinelli. Status as of November 2026.
Criteria shown is generalized based on current standards in this mass tort. Tailored criteria sets are available to meet client specifications.
Exclusive Atrazine leads: pre-screened claimants delivered in real time to your CRM, by API, by email or as a warm transfer, for your own team to sign.
Signed Atrazine retainers: our in-house intake team qualifies the claimant and collects the signed retainer and HIPAA authorization before the case is delivered.
Pricing: a percentage of ad spend, or a fixed price per signed retainer. Volume is available on request.
No. As of November 2026 there is no MDL or coordinated proceeding for atrazine personal-injury claims. The first publicly reported non-Hodgkin lymphoma suit, Panayiotou v. Syngenta AG, was filed in federal court in California in October 2026.
Non-Hodgkin lymphoma is the primary injury. Some firms also evaluate aggressive prostate cancer, so we can screen for it if your firm accepts it.
In June 2026 the Supreme Court held that FIFRA preempts state failure-to-warn claims seeking warnings beyond the EPA-approved label. Plaintiffs are pleading around it with design-defect, negligence and off-label communication theories, which courts have not yet tested for atrazine.
Yes. Each lead comes from our own ads and goes to one firm only. Every lead includes a TrustedForm certificate, and intake calls are recorded.
Yes. We offer exclusive leads or signed retainers, priced as a percentage of ad spend or a fixed price per signed retainer.
Yes. No standard exposure-duration rule has been published for atrazine, so we set the pre-screen and intake questions to your firm’s criteria.
Chlorpyrifos Leads · Roundup Leads · Paraquat Leads · Mass Tort Intake · All mass tort case leads
Prices are always changing and tend to rise over time. We work with you to get the lowest client acquisition cost in the industry by tailoring our service to your needs.
Book a time with our VP, and he’ll walk you through pricing and strategy step by step.